TY - JOUR
T1 - RS5444, a novel PPARγ agonist, regulates aspects of the differentiated phenotype in nontransformed intestinal epithelial cells
AU - Chen, Lu
AU - Bush, Craig R.
AU - Necela, Brian M.
AU - Su, Weidong
AU - Yanagisawa, Masahiro
AU - Anastasiadis, Panos Z.
AU - Fields, Alan P.
AU - Thompson, E. Aubrey
N1 - Funding Information:
This work was supported in part by grants from the National Cancer Institute (CA24347) and Sankyo Ltd. Craig R. Bush is supported by a training fellowship from the Keck Center for Computational and Structural Biology of the Gulf Coast Consortia (NLM Grant No. 5 T15-LM07093). We wish to express our thanks for excellent support from Ms. Pamela A. Kreinest of the Mayo Clinic Tumor Histology service.
PY - 2006/6/7
Y1 - 2006/6/7
N2 - Peroxisome proliferator-activated receptor-gamma (PPARγ) is expressed in the intestinal epithelium, yet little is known about the physiological role of PPARγ in the small bowel or the effects of PPARγ on small intestinal epithelial cells. The present studies investigate cellular and genomic effects of PPARγ in nontransformed rat intestinal epithelial cells (RIE). These cells were engineered to express mouse PPARγ1, and thereby to model the molecular phenotype that obtains upon induction of PPARγ at the crypt/villus junction in the small intestine. In these studies, we have used a novel third generation thiazolidinedione derivative, RS5444, which activates PPARγ with an EC50 about 1/50th that of rosiglitazone and has no effect on RIE cells that do not express PPARγ. We used Affymetrix oligonucleotide microarrays to identify potential PPARγ-regulated processes in RIE cells, including lipid metabolism, cell proliferation and differentiation, remodeling of the extracellular matrix, cell morphology, cell-cell adhesion, and motility. The genomic profile reflects cellular events that occur following PPARγ activation: RS5444 inhibited culture growth and caused irreversible G1 arrest, but did not induce apoptosis. In addition, RS5444 caused dramatic changes in cellular morphology which were associated with increased motility and diminished cellular adherence, but no increase in the ability of such cells to digest and invade Matrigel. Inhibition of proliferation, cell cycle arrest, increased motility, and altered adherence are aspects of the differentiated phenotype of villus epithelial cells, which withdraw from the cell cycle at the crypt/villus interface, migrate to the villus tips, and are subsequently shed by loss of contact with the epithelium and the underlying extracellular matrix. Our results are consistent with the hypothesis that PPARγ regulates critical aspects of differentiation in the small intestinal epithelium. Many nuclear receptors regulate differentiation. However, our results point to novel effects of PPARγ on cell-cell and cell-matrix interactions, which are not typical of other nuclear receptors.
AB - Peroxisome proliferator-activated receptor-gamma (PPARγ) is expressed in the intestinal epithelium, yet little is known about the physiological role of PPARγ in the small bowel or the effects of PPARγ on small intestinal epithelial cells. The present studies investigate cellular and genomic effects of PPARγ in nontransformed rat intestinal epithelial cells (RIE). These cells were engineered to express mouse PPARγ1, and thereby to model the molecular phenotype that obtains upon induction of PPARγ at the crypt/villus junction in the small intestine. In these studies, we have used a novel third generation thiazolidinedione derivative, RS5444, which activates PPARγ with an EC50 about 1/50th that of rosiglitazone and has no effect on RIE cells that do not express PPARγ. We used Affymetrix oligonucleotide microarrays to identify potential PPARγ-regulated processes in RIE cells, including lipid metabolism, cell proliferation and differentiation, remodeling of the extracellular matrix, cell morphology, cell-cell adhesion, and motility. The genomic profile reflects cellular events that occur following PPARγ activation: RS5444 inhibited culture growth and caused irreversible G1 arrest, but did not induce apoptosis. In addition, RS5444 caused dramatic changes in cellular morphology which were associated with increased motility and diminished cellular adherence, but no increase in the ability of such cells to digest and invade Matrigel. Inhibition of proliferation, cell cycle arrest, increased motility, and altered adherence are aspects of the differentiated phenotype of villus epithelial cells, which withdraw from the cell cycle at the crypt/villus interface, migrate to the villus tips, and are subsequently shed by loss of contact with the epithelium and the underlying extracellular matrix. Our results are consistent with the hypothesis that PPARγ regulates critical aspects of differentiation in the small intestinal epithelium. Many nuclear receptors regulate differentiation. However, our results point to novel effects of PPARγ on cell-cell and cell-matrix interactions, which are not typical of other nuclear receptors.
KW - Differentiation
KW - PPAR-gamma
KW - Small intestine
UR - http://www.scopus.com/inward/record.url?scp=33747164536&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33747164536&partnerID=8YFLogxK
U2 - 10.1016/j.mce.2006.02.006
DO - 10.1016/j.mce.2006.02.006
M3 - Article
C2 - 16574311
AN - SCOPUS:33747164536
SN - 0303-7207
VL - 251
SP - 17
EP - 32
JO - Molecular and Cellular Endocrinology
JF - Molecular and Cellular Endocrinology
IS - 1-2
ER -